Cargando…

Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus

3CL protease is one of the key proteins expressed by SARS-Coronavirus-2 cell, the potential to be targeted in the discovery of antivirus during this COVID-19 pandemic. This protein regulates the proteolysis of viral polypeptide essential in forming RNA virus. 3CL protease (3CLpro) was commonly targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartini, Yustina, Saputra, Bakti, Wahono, Bryan, Auw, Zerlinda, Indayani, Friska, Adelya, Lintang, Namba, Gabriel, Hariono, Maywan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832947/
https://www.ncbi.nlm.nih.gov/pubmed/33520632
http://dx.doi.org/10.1016/j.rechem.2020.100087
_version_ 1783641949253664768
author Hartini, Yustina
Saputra, Bakti
Wahono, Bryan
Auw, Zerlinda
Indayani, Friska
Adelya, Lintang
Namba, Gabriel
Hariono, Maywan
author_facet Hartini, Yustina
Saputra, Bakti
Wahono, Bryan
Auw, Zerlinda
Indayani, Friska
Adelya, Lintang
Namba, Gabriel
Hariono, Maywan
author_sort Hartini, Yustina
collection PubMed
description 3CL protease is one of the key proteins expressed by SARS-Coronavirus-2 cell, the potential to be targeted in the discovery of antivirus during this COVID-19 pandemic. This protein regulates the proteolysis of viral polypeptide essential in forming RNA virus. 3CL protease (3CLpro) was commonly targeted in the previous SARS-Coronavirus including bat and MERS, hence, by blocking this protein activity, the coronavirus should be eradicated. This study aims to review the potency of biflavonoid as the SARS-Coronavirus-2 3CLpro inhibitor. The review was initiated by describing the chemical structure of biflavonoid and followed by listing its natural source. Instead, the synthetic pathway of biflavonoid was also elaborated. The 3CLpro structure and its function were also illustrated followed by the list of its 3D-crystal structure available in a protein data bank. Lastly, the pharmacophores of biflavonoid have been identified as a protease inhibitor, was also discussed. This review hopefully will help researchers to obtain packed information about biflavonoid which could lead to the study in designing and discovering a novel SARS-Coronavirus-2 drug by targetting the 3CLpro enzyme.
format Online
Article
Text
id pubmed-7832947
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Author(s). Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-78329472021-01-26 Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus Hartini, Yustina Saputra, Bakti Wahono, Bryan Auw, Zerlinda Indayani, Friska Adelya, Lintang Namba, Gabriel Hariono, Maywan Results Chem Article 3CL protease is one of the key proteins expressed by SARS-Coronavirus-2 cell, the potential to be targeted in the discovery of antivirus during this COVID-19 pandemic. This protein regulates the proteolysis of viral polypeptide essential in forming RNA virus. 3CL protease (3CLpro) was commonly targeted in the previous SARS-Coronavirus including bat and MERS, hence, by blocking this protein activity, the coronavirus should be eradicated. This study aims to review the potency of biflavonoid as the SARS-Coronavirus-2 3CLpro inhibitor. The review was initiated by describing the chemical structure of biflavonoid and followed by listing its natural source. Instead, the synthetic pathway of biflavonoid was also elaborated. The 3CLpro structure and its function were also illustrated followed by the list of its 3D-crystal structure available in a protein data bank. Lastly, the pharmacophores of biflavonoid have been identified as a protease inhibitor, was also discussed. This review hopefully will help researchers to obtain packed information about biflavonoid which could lead to the study in designing and discovering a novel SARS-Coronavirus-2 drug by targetting the 3CLpro enzyme. The Author(s). Published by Elsevier B.V. 2021-01 2020-12-25 /pmc/articles/PMC7832947/ /pubmed/33520632 http://dx.doi.org/10.1016/j.rechem.2020.100087 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Hartini, Yustina
Saputra, Bakti
Wahono, Bryan
Auw, Zerlinda
Indayani, Friska
Adelya, Lintang
Namba, Gabriel
Hariono, Maywan
Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus
title Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus
title_full Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus
title_fullStr Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus
title_full_unstemmed Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus
title_short Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus
title_sort biflavonoid as potential 3-chymotrypsin-like protease (3clpro) inhibitor of sars-coronavirus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832947/
https://www.ncbi.nlm.nih.gov/pubmed/33520632
http://dx.doi.org/10.1016/j.rechem.2020.100087
work_keys_str_mv AT hartiniyustina biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus
AT saputrabakti biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus
AT wahonobryan biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus
AT auwzerlinda biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus
AT indayanifriska biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus
AT adelyalintang biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus
AT nambagabriel biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus
AT harionomaywan biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus